Evercore ISI Group Maintains Outperform on Twist Bioscience, Raises Price Target to $56
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an 'Outperform' rating on Twist Bioscience and raised its price target from $52 to $56.
October 01, 2024 | 5:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evercore ISI Group has maintained an 'Outperform' rating on Twist Bioscience and increased the price target from $52 to $56, indicating positive expectations for the stock.
The 'Outperform' rating suggests that the analyst expects Twist Bioscience to perform better than the market average. The increase in the price target from $52 to $56 indicates a positive outlook and potential for stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100